TAMMY JOHNSON: Open Payments
NPI 1720314883 · DELTAVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $445
Food & beverage: $426Education: $19
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 3 | $69 |
| Novo Nordisk Inc | 4 | $67 |
| Abbott Laboratories | 3 | $66 |
| ABBVIE INC. | 3 | $59 |
| Lilly USA, LLC | 3 | $53 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Biogen, Inc. | 1 | $15 |
Products named: ACCRUFER, FREESTYLE LIBRE 3, MOUNJARO, UBRELVY, FARXIGA, NURTEC ODT, Ozempic, JARDIANCE.
Industry payments across VA — which companies pay providers there.
